Market Overview:
The global general anesthesia medicine market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing number of surgeries, rising geriatric population, and technological advancements in anesthesiology drugs and devices. Based on type, propofol is expected to account for the largest share of the global general anesthesia medicine market in 2018. This can be attributed to its properties such as rapid onset and short duration of action, which make it suitable for use in short procedures. Inhalational anesthetics are expected to account for the second-largest share of this market during the forecast period. This can be attributed to their properties such as low toxicity and easy availability.
Product Definition:
A medical technique that produces a reversible loss of sensation, including pain, and consciousness. It is used to facilitate surgical or other invasive procedures.
Propofol:
Propofol is a general anesthetic agent that works by blocking the action of pain sensors in the brain. It is used to induce sleep and/or put patients under anesthesia during surgery or diagnostic procedures. Propofol has been approved by the U.
Etomidate:
Etomidate is an injectable drug used for the control of breathing and death in patients during surgery or treatment. Etomidate has a high margin of safety and is well-tolerated by patients, which makes it suitable for use as a general anesthesia medicine. It was first introduced into medical practice in 1960s, but got banned by most countries because of its potential to cause fatal respiratory depression.
Application Insights:
Intravenous anesthetics was the largest application segment in 2017 and is anticipated to maintain its dominance over the forecast period. The growing use of intravenous anesthetics for pain management during surgeries is one of the key factors driving this segment. Intravenous anesthesia has a rapid onset of action, which helps in reducing postoperative pain after surgery, thereby making it ideal for various surgical procedures.
The inhalational anesthetics segment is expected to grow at a significant rate over the forecast period owing to rising awareness about sleep apnea and other respiratory problems among adults. According to data published by Centers for Disease Control and Prevention (CDC), around 1 in 25 children suffer from some form of sleep apnea compared with 1 out of 15 adults aged 60 years or above suffering from mild sleep apnea while sleeping at night time.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as favorable reimbursement scenario, rising awareness about advanced surgeries and availability of highly skilled physicians. Moreover, increasing demand for cosmetic surgeries is also expected to drive the regional market during the forecast period. Asia Pacific is expected to witness lucrative growth over the coming years owing to improving healthcare infrastructure and growing medical tourism in emerging countries such as India, China and Malaysia. Furthermore, an increase in surgical procedures due to a rise in population will boost product demand further.
Growth Factors:
- Increasing demand for general anesthesia in outpatient and ambulatory surgery centers
- Rising prevalence of chronic diseases and disorders that require surgical intervention
- Growing number of aging population who are more susceptible to surgical procedures
- Technological advancements in the field of general anesthesia that improve patient safety
- Increasing healthcare expenditure by governments and private players to support provision of quality healthcare services
Scope Of The Report
Report Attributes
Report Details
Report Title
General Anesthesia Medicine Market Research Report
By Type
Propofol, Etomidate, Midazolam, Sevoflurane, Isoflurane, Others
By Application
Intravenous Anesthetics, Inhalational Anesthetics
By Companies
Astrazeneca, B.Braun, Fresenius-Kabi, Hikma Pharmaceuticals, Maruishi, Nhwa, Piramal, AbbVie, Baxter Healthcare, Hengrui, Lunan, Mylan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global General Anesthesia Medicine Market Report Segments:
The global General Anesthesia Medicine market is segmented on the basis of:
Types
Propofol, Etomidate, Midazolam, Sevoflurane, Isoflurane, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Intravenous Anesthetics, Inhalational Anesthetics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Astrazeneca
- B.Braun
- Fresenius-Kabi
- Hikma Pharmaceuticals
- Maruishi
- Nhwa
- Piramal
- AbbVie
- Baxter Healthcare
- Hengrui
- Lunan
- Mylan
Highlights of The General Anesthesia Medicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Propofol
- Etomidate
- Midazolam
- Sevoflurane
- Isoflurane
- Others
- By Application:
- Intravenous Anesthetics
- Inhalational Anesthetics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the General Anesthesia Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
General anesthesia medicine is a medical specialty that specializes in providing general anesthetics, including propofol and etomidate, to patients for surgery or other medical procedures.
Some of the major companies in the general anesthesia medicine market are Astrazeneca, B.Braun, Fresenius-Kabi, Hikma Pharmaceuticals, Maruishi, Nhwa, Piramal, AbbVie, Baxter Healthcare, Hengrui, Lunan, Mylan.
The general anesthesia medicine market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 General Anesthesia Medicine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 General Anesthesia Medicine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 General Anesthesia Medicine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the General Anesthesia Medicine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global General Anesthesia Medicine Market Size & Forecast, 2018-2028
4.5.1 General Anesthesia Medicine Market Size and Y-o-Y Growth
4.5.2 General Anesthesia Medicine Market Absolute $ Opportunity
Chapter 5 Global General Anesthesia Medicine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 General Anesthesia Medicine Market Size Forecast by Type
5.2.1 Propofol
5.2.2 Etomidate
5.2.3 Midazolam
5.2.4 Sevoflurane
5.2.5 Isoflurane
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global General Anesthesia Medicine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 General Anesthesia Medicine Market Size Forecast by Applications
6.2.1 Intravenous Anesthetics
6.2.2 Inhalational Anesthetics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global General Anesthesia Medicine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 General Anesthesia Medicine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America General Anesthesia Medicine Analysis and Forecast
9.1 Introduction
9.2 North America General Anesthesia Medicine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America General Anesthesia Medicine Market Size Forecast by Type
9.6.1 Propofol
9.6.2 Etomidate
9.6.3 Midazolam
9.6.4 Sevoflurane
9.6.5 Isoflurane
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America General Anesthesia Medicine Market Size Forecast by Applications
9.10.1 Intravenous Anesthetics
9.10.2 Inhalational Anesthetics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe General Anesthesia Medicine Analysis and Forecast
10.1 Introduction
10.2 Europe General Anesthesia Medicine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe General Anesthesia Medicine Market Size Forecast by Type
10.6.1 Propofol
10.6.2 Etomidate
10.6.3 Midazolam
10.6.4 Sevoflurane
10.6.5 Isoflurane
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe General Anesthesia Medicine Market Size Forecast by Applications
10.10.1 Intravenous Anesthetics
10.10.2 Inhalational Anesthetics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific General Anesthesia Medicine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific General Anesthesia Medicine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific General Anesthesia Medicine Market Size Forecast by Type
11.6.1 Propofol
11.6.2 Etomidate
11.6.3 Midazolam
11.6.4 Sevoflurane
11.6.5 Isoflurane
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific General Anesthesia Medicine Market Size Forecast by Applications
11.10.1 Intravenous Anesthetics
11.10.2 Inhalational Anesthetics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America General Anesthesia Medicine Analysis and Forecast
12.1 Introduction
12.2 Latin America General Anesthesia Medicine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America General Anesthesia Medicine Market Size Forecast by Type
12.6.1 Propofol
12.6.2 Etomidate
12.6.3 Midazolam
12.6.4 Sevoflurane
12.6.5 Isoflurane
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America General Anesthesia Medicine Market Size Forecast by Applications
12.10.1 Intravenous Anesthetics
12.10.2 Inhalational Anesthetics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) General Anesthesia Medicine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) General Anesthesia Medicine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) General Anesthesia Medicine Market Size Forecast by Type
13.6.1 Propofol
13.6.2 Etomidate
13.6.3 Midazolam
13.6.4 Sevoflurane
13.6.5 Isoflurane
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) General Anesthesia Medicine Market Size Forecast by Applications
13.10.1 Intravenous Anesthetics
13.10.2 Inhalational Anesthetics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 General Anesthesia Medicine Market: Competitive Dashboard
14.2 Global General Anesthesia Medicine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Astrazeneca
14.3.2 B.Braun
14.3.3 Fresenius-Kabi
14.3.4 Hikma Pharmaceuticals
14.3.5 Maruishi
14.3.6 Nhwa
14.3.7 Piramal
14.3.8 AbbVie
14.3.9 Baxter Healthcare
14.3.10 Hengrui
14.3.11 Lunan
14.3.12 Mylan
